Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer

Loading...
Thumbnail Image
Files
Date
2024-06-27T00:00:00Z
Authors
Pappa, Christina
Galaal, Khadra
Smyth, Sarah
Bristow, Robert E.
Khashan, Ali S.
Alazzam, Mo'iad
Journal Title
Journal ISSN
Volume Title
Publisher
John Wiley & Sons, Inc.
Research Projects
Organizational Units
Journal Issue
Abstract
This is a protocol for a Cochrane Review (intervention). The objectives are as follows: To evaluate the benefits and harms of secondary CRS and chemotherapy in comparison to chemotherapy alone for women with platinum-sensitive recurrent epithelial ovarian cancer.
Description
Keywords
Cytoreductive surgery plus chemotherapy , Chemotherapy alone , Recurrent epithelial ovarian cancer
Citation
Pappa, C., Galaal, K., Smyth, S., Bristow, R. E., Khashan, A. S. and Alazzam, M. (2024) 'Cytoreductive surgery plus chemotherapy versus chemotherapy alone for recurrent epithelial ovarian cancer', Cochrane Database of Systematic Reviews 2024, Issue 6, CD015297 (15pp). https://doi.org/10.1002/14651858.CD015297 (Accessed: 11 July 2024)
Link to publisher’s version
Copyright
© 2024, The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.